Journal of Cardiovascular Pharmacology and Therapeutics

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, K. E.
Right arrow Articles by Caffrey, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, K. E.
Right arrow Articles by Caffrey, J. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 6, No. 4, 385-393 (2001)
DOI: 10.1177/107424840100600408

Delta Opioid Receptors Inhibit Vagal Bradycardia in the Sinoatrial Node

Keith E. Jackson

Martin Farias

Amber Stanfill

James L. Caffrey

Department of Integrative Physiology and Cardiovascular Research Institute, University of North Texas Health Science Center in Fort Worth, Fort Worth, Texas 76107

Background: Methionine-enkephalin-arginine-phenylalanine (MEAP) is an endogenous opiate derived from the C-terminal sequence of the larger precursor molecule proenkephalin. This heptapeptide is abundant in the myocardium and has significant vagolytic activity when infused systemically. MEAP interrupted vagal bradycardia when it was delivered directly into the sinoatrial node by local microdialysis. This study was conducted to determine the opioid receptor responsible for the vagolytic effect of MEAP.

Methods and Results: Microdialysis probes were placed in the sinoatrial node of mongrel dogs and perfused at 5 µL/min. Increasing doses of MEAP were included in the nodal perfusate and approximately two thirds of the vagal bradycardia was inhibited with a maximal effect at 0.3 nmoles/µ,L and a half-maximal response near 0.1 nmoles/,uL. When deltorphin II (a delta opioid receptor agonist) was infused into the sinoatrial node, more than 95% of the vagal bradycardia was eliminated at 0.3 nmoles/,uL with the half-maximal response near 0.1 nmoles/,L, indicating that deltorphin II was more efficacious than MEAP. The maximal deltorphin II and MEAP effects were both similarly reversed by the paired infusion of increasing doses of the 6 opiate receptor antagonist, naltrindole. Selected, µ (endomorphin, super DALDA) and {kappa} (dynorphin, U50488) receptor agonists and,µ (CTAP) and {kappa} (norBNI) receptor antagonists were completely ineffective in this system.

Conclusions: These data suggest that the vagolytic effect of MEAP involves the activation of delta opiate receptors within the sinoatrial node.

Key Words: heart rate • microdialysis • enkephalin MEAP • anticholinergic


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. H. Deo, S. Johnson-Davis, M. A. Barlow, D. Yoshishige, and J. L. Caffrey
Repeated {delta}1-opioid receptor stimulation reduces {delta}2-opioid receptor responses in the SA node
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2246 - H2254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Davis, S. H. Deo, M. Barlow, D. Yoshishige, M. Farias, and J. L. Caffrey
The monosialosyl ganglioside GM-1 reduces the vagolytic efficacy of {delta}2-opioid receptor stimulation
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2318 - H2326.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. A. Barlow, S. Deo, S. Johnson, and J. L. Caffrey
Vagotonic effects of enkephalin are not mediated by sympatholytic mechanisms.
Experimental Biology and Medicine, April 1, 2006; 231(4): 387 - 395.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Pepe, O. W.V van den Brink, E. G Lakatta, and R.-P. Xiao
Cross-talk of opioid peptide receptor and {beta}-adrenergic receptor signalling in the heart
Cardiovasc Res, August 15, 2004; 63(3): 414 - 422.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Farias III, K. Jackson, M. Johnson, and J. L. Caffrey
Cardiac enkephalins attenuate vagal bradycardia: interactions with NOS-1-cGMP systems in canine sinoatrial node
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2001 - H2012.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. A. Stanfill, K. Jackson, M. Farias, M. Barlow, S. Deo, S. Johnson, and J. L. Caffrey
Leucine-Enkephalin Interrupts Sympathetically Mediated Tachycardia Prejunctionally in the Canine Sinoatrial Node
Experimental Biology and Medicine, September 1, 2003; 228(8): 898 - 906.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. F. K. Jackson, D. Yoshishige, and J. L. Caffrey
Bimodal {delta}-opioid receptors regulate vagal bradycardia in canine sinoatrial node
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1332 - H1339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Farias III, K. E. Jackson, D. Yoshishige, and J. L. Caffrey
Cardiac enkephalins interrupt vagal bradycardia via delta 2-opioid receptors in sinoatrial node
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1693 - H1701.
[Abstract] [Full Text] [PDF]